Metropolis Healthcare Ltd.

NSE: METROPOLIS | BSE: 542650 | ISIN: INE112L01020 | Industry: Healthcare Services
| Momentum Trap
1875.5000 0.40 (0.02%)
NSE Jan 13, 2026 09:24 AM
Volume: 2,450
 

1875.50
0.02%
ICICI Securities Limited
Metropolis delivered a strong beat in operational performance in Q2FY26 led by renewed focus on margin improvement. Metropolis is unlikely to pursue any acquisition in the near term, until the company completes the integration of its recently acquired assets like Core Diagnostics.
Number of FII/FPI investors increased from 171 to 177 in Sep 2025 qtr.
More from Metropolis Healthcare Ltd.
Recommended